WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Cell Dissociation Market has been steadily growing due to technological developments in cell separation and the rise in demand for cell-based medicines. As more uses for Cell Dissociation in academic and medical settings are developed, this market is anticipated to expand.
According to Vantage Market Research, the global Cell Dissociation Market is estimated to be USD 1.4 Billion by 2030 and is expected to exhibit a CAGR of 18.2% from 2023 to 2030. The global Cell Dissociation market grew to USD 0.4 Billion in 2022.
Cell dissociation involves separating cells from a tissue or organ sample to allow for the study of individual cell characteristics and functions. This technique is crucial in various applications such as drug discovery, regenerative medicine, and cancer research. Collecting the desired cell sample from the host tissue is always the first step when working with cells of any kind (immune cells, tumor cells, etc.). Dissociation, or disaggregation, is the breakdown of a cell culture to obtain a discrete group of cells.
Get Access to Free Sample Research Report with Latest Industry Insights @ https://www.vantagemarketresearch.com/cell-dissociation-market-2259/request-sample
Key Highlights
- By Product, the Enzymatic dissociation segment dominated the global market in 2022 and accounted for the maximum share of more than 48% of the overall revenue.
- By End-User, the pharmaceutical and biotechnology companies dominated the market in 2022 and accounted for the maximum share of more than 72.23%
- North America is the largest region for the Cell Dissociation market in 2022, accounting for the maximum share of more than 38% of the overall revenue.
- By Type, the tissue dissociation type segment dominated the global market in 2022 and accounted for the maximum share of 55% of the overall revenue.
Numerous industries use the cell dissociation market, including research institutions, biotechnology and pharmaceutical firms, and clinical laboratories. It makes isolating and separating cells from tissues and organs easier, allowing for more in-depth examination and experimentation. Enzymes, reagents, and kits are available v. These methods are essential for researching cancer, drug discovery, regenerative medicine, and cell behavior. Growing innovations in this market guarantee increased efficacy and accuracy in cell dissociation, enabling more precise scientific and medical advancements.
Top Companies in The Global Cell Dissociation Market
- VitaCyte LLC (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Merck KGaA (Germany)
- HiMedia Laboratories Pvt. Ltd. (India)
- Miltenyi Biotec GmbH (Germany)
- STEMCELL Technologies Inc. (Canada)
- General Electric Company (U.S.)
- Roche Diagnostics (Switzerland)
- Becton Dickinson & Company (U.S.)
- PAN-Biotech GMBH (Germany)
To Know an Additional List of Key Players, Request Here to Download a Free Report PDF Brochure: https://www.vantagemarketresearch.com/cell-dissociation-market-2259/request-sample
OR
Enjoy a Fabulous 50% Discount with code "SEP50"! Don't miss out on these incredible savings @ https://www.vantagemarketresearch.com/buy-now/cell-dissociation-market-2259/0
Factors Affecting the Growth of the Cell Dissociation Market
Several factors can affect the growth of the Cell Dissociation industry. Some of these factors include:
- Increasing Research and Development Activities: Rising investments in research and development activities in stem cell research, regenerative medicine, and drug discovery are driving the demand for Cell Dissociation products. Continuous innovations and developments to improve Cell Dissociation protocols are further propelling the market growth.
- Growing Prevalence of Chronic Diseases: The widespread presence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders is fueling the demand for the isolation and purification of specific cell types. Cell Dissociation techniques are widely used in disease modeling, drug discovery, and personalized medicine, thus driving market growth.
- Advancements in Cell Dissociation Techniques: Technological advancements in Cell Dissociation techniques, such as the development of enzymatic and non-enzymatic methods, have improved the efficiency and accuracy of cell dissociation procedures. These advancements are attracting researchers and industries towards adopting Cell Dissociation products, thereby driving market growth.
- Growing Investments in Stem Cell Research: Increasing investments in stem cell research, especially for developing novel therapies and regenerative medicine, are expected to drive the demand for Cell Dissociation products. Stem cell-based therapies hold immense potential in treating various diseases and injuries, creating a favorable market landscape for Cell Dissociation products.
- Rising Demand for Cell-Based Assays: Cell-based assays are extensively used in drug discovery, toxicity testing, and disease modeling, among other applications. The increasing adoption of cell-based assays is driving the demand for Cell Dissociation products to generate homogeneous cell populations.
Top Trends in the Global Cell Dissociation Market
Several significant trends have emerged in the cell dissociation market in recent years. First, there is an increasing need for accurate and reliable automated cell dissociation systems. Automation products like gentleMACS Dissociators, which provide standardized and repeatable dissociation protocols, are available from businesses like Miltenyi Biotec. Second, there is a growing emphasis on the creation of fresh dissociation agents and enzymes that can improve cell dissociation procedures. For instance, BioLegend offers a variety of dissociation reagents like TrypLE Select that outperform conventional enzymes in terms of cell viability and recovery. These patterns reflect the market's preference for high-quality dissociated cells that are more efficient, dependable, and suitable for use in research and clinical settings.
Buy this Premium Research Report with Discount | Immediate Delivery @ https://www.vantagemarketresearch.com/buy-now/cell-dissociation-market-2259/0
Recent Development of the Global Cell Dissociation Market
- On March 10, 2023, Agilent Technologies Inc. announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell.
- On September 21, 2022, S2 Genomics, Inc., a leading developer of laboratory automation solutions for processing solid tissues for life science applications, announced that it has entered into a distribution agreement with Proteigene for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in France.
- On March 1, 2022, LevitasBio Inc. announced the launch of their LeviPrep™ and LeviSelect™ product lines. Developed to work with the LeviCell™ system, these solutions streamline the processing of human and mouse tissue and cell samples used in advanced biological research.
Market Drivers
The rising importance of regenerative medicine and cell-based therapies primarily drives the market for Cell Dissociation. Techniques for dissociating individual cells from tissues or cell cultures are essential for conducting further analysis and manipulation. The prevalence of chronic diseases is increasing, and the need for personalized medicine is also rising, which has helped the market expand. Furthermore, technological developments like automated Cell Dissociation systems and the use of enzymatic solutions have increased the precision and efficacy of Cell Dissociation procedures. These market drivers highlight the significance of Cell Dissociation in numerous applications, from research to drug development.
Market Restraints
Several restraints prevent the Cell Dissociation market from expanding and becoming widely used. First off, the expensive nature of Cell Dissociation techniques limits their use in many labs and research settings. Second, Cell Dissociation techniques' complexity prevents them from being widely used because accurate and effective results necessitate trained personnel and sophisticated tools. Specific Cell Dissociation techniques, such as enzymes, are subject to ethical considerations and regulatory requirements, which further restrain the market's growth. Despite these obstacles, market expansion is anticipated thanks to technological developments like the creation of automated cell dissociation systems that will help overcome some of these limitations.
Market Opportunities
The rising demand for individualized medicine and regenerative therapies is anticipated to lead to significant growth in the Cell Dissociation market over the ensuing years. Cell Dissociation is an essential step in many applications, including cell-based assays, cell therapy, and stem cell research. The main market drivers are the rising incidence of chronic diseases, improvements in cell culture methods, and the demand for efficient cell isolation techniques. Additionally, there are a lot of opportunities on the market for cutting-edge technologies that allow for efficient and delicate cell dissociation without compromising cell viability and functionality.
Browse market data Tables and Figures spread through 149 Pages and in-depth TOC on Cell Dissociation Market Forecast Report (2023-2030).
Report Segmentation of the Global Cell Dissociation Market
Product Type Analysis
Enzymatic dissociation products have recently dominated the market for Cell Dissociation among its many product categories. These products use enzymes to dissolve the extracellular matrix and cell-cell adhesions that bind cells together, enabling their separation and clearance. Researchers prefer enzymatic dissociation to non-enzymatic dissociation because it occurs more quickly and gently. Enzymatic dissociation dominates the Cell Dissociation market, in large part due to its adaptability. Collagenase, trypsin, and papain are some of the enzymes that can be modified to accommodate different cell types and tissues. Collagenase, for instance, is very effective at breaking down collagen-rich tissues, whereas trypsin is effective at separating adherent cell lines. Cell Dissociation devices like tissue homogenizers and bead mills are also becoming more popular, and consumable cell strainers and microcentrifuge tubes are crucial steps in the procedure.
Type Analysis
Because of its adaptability and effectiveness in removing viable cells from various tissues, tissue dissociation dominates the Cell Dissociation market. This technique uses mechanical or enzymatic means to separate cells from tissues, allowing for downstream uses like cell culture, gene expression analysis, and flow cytometry. Compared to other techniques like scraping or sieving, tissue dissociation guarantees a higher yield of viable cells because it reduces cell damage and preserves cellular integrity. For instance, collagenase-based enzyme dissociation has been widely used to effectively dissociate various tissues, including the pancreas, lungs, and liver. Due to its efficiency and suitability for various tissues, tissue dissociation has become the method of choice for scientists and researchers in the Cell Dissociation market.
End-User Analysis
Pharmaceutical and biotechnology companies dominate the market for Cell Dissociation because of their distinct resources and capabilities. These businesses can create cutting-edge Cell Dissociation products because they have access to cutting-edge technology and a wealth of knowledge in cell biology. Additionally, they make significant R&D investments, allowing them to explore novel approaches and enhance current ones for effective cell dissociation. These businesses partner with research organizations and academic institutions to advance their subject-matter expertise. Additionally, they have a robust distribution network that makes their Cell Dissociation products widely available. Additionally, pharmaceutical and biotechnology companies employ quality control procedures and regulatory expertise to ensure that their products adhere to strict standards and provide consistent, repeatable results for various applications.
Read Full Report with TOC @ https://www.vantagemarketresearch.com/industry-report/cell-dissociation-market-2259
Market Segmentation
By Product
- Enzymatic dissociation products
- Non-enzymatic dissociation products
- Instruments and Accessories
- Other Products
By Type
- Cell Detachment
- Tissue Dissociation
- Other Types
By End-User
- Academic & Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Hospitals & Diagnostic Laboratories
- Other End-Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Scope of the Report:
| Report Attributes | Details |
| Market Size in 2022 | USD 0.4 Billion |
| Revenue Forecast by 2030 | USD 1.4 Billion |
| CAGR | 18.2% from 2023 to 2030 |
| Base Year | 2022 |
| Forecast Year | 2023 to 2030 |
| Key Players | VitaCyte LLC, Thermo Fisher Scientific Inc., Merck KGaA, HiMedia Laboratories Pvt. Ltd., Miltenyi Biotec GmbH, STEMCELL Technologies Inc., General Electric Company, Roche Diagnostics, Becton Dickinson & Company, PAN-Biotech GMBH |
| Customization Options | Customized purchase options are available to meet any research needs. Explore customized purchase options https://www.vantagemarketresearch.com/cell-dissociation-market-2259/customization-request |
Regional Analysis
The Cell Dissociation Market's regional analysis reveals significant growth potential in numerous parts of the world. Due to its superior research infrastructure, established healthcare system, and rising stem cell research expenditures, North America commands the market. The presence of major pharmaceutical and biotech corporations helps this region's market grow. The rising incidence of chronic diseases and the rising demand for regenerative medicine are major growth drivers in Europe. Government programs supporting research and development in stem cell therapies also contribute to the market's expansion. Due to the growing geriatric population, expanding healthcare industry, and rising investments in healthcare infrastructure, the Asia Pacific region is predicted to grow fastest. Additionally, a sizable patient population and increased emphasis on cutting-edge therapies fuel market expansion in this area. According to the regional analysis, the market outlook for Cell Dissociation is positive.
Browse More Reports from Vantage Library:
Cell and Gene Therapy Manufacturing Market - Global Industry Assessment & Forecast: https://www.vantagemarketresearch.com/industry-report/cell-and-gene-therapy-manufacturing-market-2227
Single Cell Analysis Market - Global Industry Assessment & Forecast: https://www.vantagemarketresearch.com/industry-report/single-cell-analysis-market-1295
Cell Isolation Market - Global Industry Assessment & Forecast: https://www.vantagemarketresearch.com/industry-report/cell-isolation-market-1278
Stem Cell Therapy Market - Global Industry Assessment & Forecast: https://www.vantagemarketresearch.com/industry-report/stem-cell-therapy-market-2236
3D Cell Culture Market - Global Industry Assessment & Forecast: https://www.vantagemarketresearch.com/industry-report/3d-cell-culture-market-1286
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies.
Follow Us on: LinkedIn | Twitter | Facebook | YouTube
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: sales@vantagemarketresearch.com
Website:
https://www.vantagemarketresearch.com/
Latest Vantage Market Research Press Releases
Latest Vantage Market Research Blog
Vantage Market Research All Reports
Blog:
